News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
McArthur James G
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/09/2023 |
4
| McArthur James G (President and CEO) has filed a Form 4 on PepGen Inc.
Txns:
| Sold 2,381 shares
@ $16.0386, valued at
$38.2k
Exercised 2,381 options to buy
@ $2.71, valued at
$6.5k
|
|
06/08/2023 |
4
| McArthur James G (President and CEO) has filed a Form 4 on PepGen Inc.
Txns:
| Sold 18,150 shares
@ $16.1796, valued at
$293.7k
Sold 8,419 shares
@ $16.2273, valued at
$136.6k
Exercised 18,150 options to buy
@ $2.71, valued at
$49.2k
Exercised 8,419 options to buy
@ $2.71, valued at
$22.8k
|
|
06/06/2023 |
4
| McArthur James G (President and CEO) has filed a Form 4 on PepGen Inc.
Txns:
| Sold 1,800 shares
@ $16.035, valued at
$28.9k
Sold 500 shares
@ $16.056, valued at
$8k
Exercised 1,800 options to buy
@ $2.71, valued at
$4.9k
Exercised 500 options to buy
@ $2.71, valued at
$1.4k
|
|
06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
03/02/2023 |
4
| McArthur James G (President and CEO) has filed a Form 4 on PepGen Inc.
Txns:
| Granted 275,000 options to buy
@ $15.25, valued at
$4.2M
|
|
05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/16/2020 |
4
| McArthur James G (Director) has filed a Form 4 on IMARA Inc.
Txns:
| Granted 15,457 options to buy
@ $16, valued at
$247.3k
|
|
03/11/2020 |
3
| McArthur James G (Director) has filed a Form 3 on IMARA Inc. |
06/07/2019 |
4
| McArthur James G (Director) has filed a Form 4 on Nightstar Therapeutics plc
Txns:
| Disposed/sold 37,237 shares
@ $25.5, valued at
$949.5k
Disposed/sold 18,200 options to buy
@ $12.27, valued at
$223.3k
Disposed/sold 21,000 options to buy
@ $13.57, valued at
$285k
|
|
01/29/2019 |
4
| McArthur James G (Director) has filed a Form 4 on Nightstar Therapeutics plc
Txns:
| Granted 21,000 options to buy
@ $13.57, valued at
$285k
|
|
01/02/2019 |
3
| McArthur James G (Director) has filed a Form 3 on Nightstar Therapeutics plc |
|
|